EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development
● Funding round led by Nexus NeuroTech Ventures and Venture Investors Health Fund ● New investment will advance R&D efforts of first-in-kind autism diagnostic and assessment tool in toddlers April 02, 2024 06:22 AM Pacific Daylight Time…
